Citius Oncology, Inc. Cash Flow Reinvestment Rate
Citius Oncology, Inc. cash flow reinvestment rate. Citius Oncology, Inc. (CTOR) has a Cash Flow Reinvestment Rate of 0.00x as of September 2024, reinvesting $0.46 (capex $0.46 ) from operating cash flow of $900.29K. Explore CTOR debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Citius Oncology, Inc. (2024–2024)
Cash flow reinvestment rate of Citius Oncology, Inc. from 2024 to 2024. Historical reinvestment intensity for Citius Oncology, Inc. across 1 annual periods. Explore Citius Oncology, Inc. capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Citius Oncology, Inc. Cash Flow Reinvestment Rate by Year (2024–2024)
Citius Oncology, Inc. cash flow reinvestment rate by year from 2024 to 2024. Year-by-year capital reinvestment analysis for Citius Oncology, Inc.. For the full cash flow conversion analysis, see Citius Oncology, Inc. (CTOR) cash conversion ratio.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 39.57x | $5.00 Million | $126.35K | $4.00 | — |